Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT01696760
Eligibility Criteria:
Inclusion Criteria:
-Scheduled or to be scheduled for surgery performed on neoplasms of the pelvis or lower limbs, including both primary musculoskeletal lesions as well as metastatic lesions; these neoplasms may include major tumor resections, metastatic and pathologic fractures of the hip and lower extremities (LE), open biopsies, and primary malignant tumors; an active malignant neoplasm must be present at the time of surgery
Exclusion Criteria:
* Prior history of DVT or PE
* Previously placed vena cava filter
* No detectable malignant disease at the time of operation
* Previous arterial thrombosis (myocardial infarction \[MI\], cerebral vascular accident \[CVA\])
* Severe platelet dysfunction (uremia, medications, dysplastic hematopoiesis); excluded if platelets \< 50,000
* Preoperative anticoagulation or active/serious bleeding in past 2 weeks (prothrombin time \[PT\] \& partial thromboplastin time \[PTT\] \> 1.6 \& \> 35)
* Hypersensitivity or allergy to aspirin or heparin (including those diagnosed with heparin-induced thrombocytopenia)
* Conditions associated with bleeding (active ulcer disease, recent neurosurgery, bleeding disorders)
* Patients with renal insufficiency (creatinine \[Cr\] \> 1.5)
* Pregnant patients
* Epidural anesthesia
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01696760
Study Brief:
Protocol Section:
NCT01696760